Prilosec and Costochondritis - a phase IV clinical study of FDA data
Summary:
Costochondritis is found among people who take Prilosec, especially for people who are female, 60+ old, have been taking the drug for 5 - 10 years.
The phase IV clinical study analyzes which people take Prilosec and have Costochondritis. It is created by eHealthMe based on reports of 158,435 people who have side effects when taking Prilosec from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
158,435 people reported to have side effects when taking Prilosec.
Among them, 133 people (0.08%) have Costochondritis.
What is Prilosec?
Prilosec has active ingredients of omeprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 161,966 Prilosec users for its effectiveness, alternative drugs and more.
What is Costochondritis?
Costochondritis (chest wall pain) is found to be associated with 951 drugs and 532 conditions by eHealthMe.
Number of Prilosec and Costochondritis reports submitted per year:
Time on Prilosec when people have Costochondritis *:
Gender of people who have Costochondritis when taking Prilosec*:
Age of people who have Costochondritis when taking Prilosec *:
Common drugs people take besides Prilosec *:
Common side effects people have besides Costochondritis *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Prilosec and have Costochondritis?
Check whether Costochondritis is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Alternative drugs to, pros and cons of Prilosec:
- Prilosec (161,966 reports)
Costochondritis treatments and more:
- Costochondritis (2,539 reports)
COVID vaccines that are related to Costochondritis:
- Costochondritis in Moderna COVID Vaccine
- Costochondritis in Pfizer BioNTech Covid Vaccine
- Costochondritis in Johnson and Johnson Covid Vaccine
How severe was Costochondritis and when was it recovered:
Expand to all the drugs that have ingredients of omeprazole:
- Costochondritis and drugs with ingredients of omeprazole (211 reports)
Common drugs associated with Costochondritis:
- Ambien: 109 reports
- Aredia: 127 reports
- Aspirin: 152 reports
- Celebrex: 132 reports
- Enbrel: 110 reports
- Fosamax: 217 reports
- Humira: 131 reports
- Lipitor: 108 reports
- Methotrexate: 170 reports
- Prednisone: 207 reports
- Prevacid: 106 reports
- Prilosec: 133 reports
- Protonix: 114 reports
- Synthroid: 142 reports
- Vioxx: 246 reports
- Zometa: 146 reports
All the drugs that are associated with Costochondritis:
- Costochondritis (951 drugs)
Common conditions associated with Costochondritis:
- Osteoporosis: 178 reports
- Pain: 144 reports
- Pain exacerbated: 144 reports
- Pain management: 144 reports
- Pain relief by acupuncture: 144 reports
- Ra: 196 reports
- Rheumatoid arthritis: 196 reports
All the conditions that are associated with Costochondritis:
- Costochondritis (532 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on omeprazole (the active ingredients of Prilosec) and Prilosec (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cellulitis and Transfusion Reaction - 5 seconds ago
- Divalproex and Astelin drug interaction - 17 seconds ago
- Velivet and Ortho Evra drug interaction - 22 seconds ago
- Mexiletine Hydrochloride and Ischaemic Cardiomyopathy - 24 seconds ago
- Lamictal and Gravol drug interaction - 26 seconds ago